Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN114605458A details a novel Rh-catalyzed C-C bond activation method for high-purity chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN110305010A details a green Grignard route for 2 5-dimethylphenylacetic acid. This method eliminates toxic cyanide and noble metals, ensuring cost reduction and supply reliability.
Patent CN118026867B details a high-efficiency chiral resolution for Mirogabalin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105198811B reveals a metal-free synthesis route for 1,3-isoquinolinedione derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN116925146A reveals efficient synthesis for battery additives and peptide coupling. Reduces cost and simplifies supply chain for global buyers.
Novel sulfuric acid assisted chlorination process enhances selectivity and yield for UV curing coatings manufacturing supply chain efficiency.
Novel patent CN103880770B enables high-purity chiral morpholine intermediates with reduced costs and scalable supply chain solutions for global pharmaceutical partners.
Novel two-step synthesis for Repaglinide intermediate offering high purity, recyclable solvents, and significant cost reduction in API manufacturing.
Patent CN108929217B reveals a novel Grignard route for high-purity intermediates. This method ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.
Patent CN101346352B reveals a novel rhodium-catalyzed asymmetric reduction for Mitiglinide intermediates, offering superior optical purity and industrial scalability for pharmaceutical manufacturers.
Advanced synthesis of ursolic acid pyrimidine amide derivatives via novel heterocyclic modification. Reliable supplier for high-purity antitumor pharmaceutical intermediates.
Patent CN101654445B reveals a cost-effective route for Ramelteon intermediates using mild conditions. This ensures supply chain stability and high purity for global pharmaceutical manufacturers seeking reliable partners.
Patent CN103897028A details a heavy-metal-free synthesis of Bortezomib, offering high purity and cost reduction for pharmaceutical manufacturing supply chains.
Patent CN1019300B reveals a direct acylation method for 7-amino-cephalosporins using acid salts, offering superior purity and cost efficiency for pharmaceutical manufacturers.
Patent CN1019300B reveals a novel acylation method for cephalosporins using acid addition salts, offering high purity and simplified processing for reliable pharmaceutical intermediates supply.
Patent CN1019300B reveals stable amine salt acylation for high-yield cephalosporins, offering cost-effective supply chain solutions.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.